MedPath

Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge

Not Applicable
Not yet recruiting
Conditions
Osteoporosis Risk
Osteoporosis, Postmenopausal
Registration Number
NCT07034131
Lead Sponsor
SingHealth Polyclinics
Brief Summary

This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.

Detailed Description

This study will involve evaluating the preliminary effectiveness and feasibility outcomes of the use of Osteo-Buddy, a Virtual Health Assistant (VHA), in improving the knowledge of osteoporosis in women aged 50 and above.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Age 50 and above
  • Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
  • Not undertaken Bone Mineral Density (BMD) scan
  • Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
  • Able to read and speak English
  • Currently use and own a smartphone where Osteo-Buddy can be used
Exclusion Criteria
  • Known terminal illness
  • Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Osteoporosis Prevention and Awareness Tool (OPAAT) scoreOn enrolment and 6-8 weeks post enrolment

* 30-item questionnaire measuring osteoporosis knowledge

* Minimum value = 0, maximum value = 30

* Higher scores indicate a better outcome

System Usability Scale (SUS)6-8 weeks post enrolment

* 10-item questionnaire assessing usability

* Minimum value = 0, maximum value = 100

* Higher scores mean a better outcome

Secondary Outcome Measures
NameTimeMethod
Retention rate6-8 weeks post-enrolment

Percentage of recruited participants who complete the study (return for 2nd visit and successfully complete 2nd questionnaire)

Utility rate4 weeks

Percentage of intervention arm participants who utilise Osteo-Buddy over the 4 weeks

Recruitment rateover the course of recruitment, estimated 3-4 months

Percentage of participants successfully recruited among referred participants

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.